The very small 'proof of concept' Sahamamy plant - 3,000t pa.
It only operated at 2/3 of nameplate capacity in H1 (1,060t produced; 950t sold) owing to various Covid restrictions.
Even so, it achieved a gross margin of 54%.
2/20
The second plant, Vatomina, is three times the size, at 9,000t pa. It came online this Q.
A third plant, Sahamamy 2, is now under development, and is coming online within 6 months. It will have capacity of 18,000t pa.
#TGR's nameplate capacity as at 01.07.2022: 30kt pa.
3/20
#TGR has been achieving a basket price of £600 per ton. At 56% gross margin, at nameplate capacity, @Tirupatiuk would be entering H2 next calendar year on an annual run rate of £10m gross profit, on revs of £18m.
£3.5m for central overheads, puts TGR on a PBT of £6.5m.
4/20
From late H2 next year, #TGR will then be able to assess when to bring modules 2, 3 and 4 at Vatomina, online. These will each be twice the size of the now producing module 1, at 18kt pa each.
Critical to note: capex for each module will only be circa $6m.
5/20
At 84kt pa, assuming a basket price of £600/t and an improved GM of 62% (economies of scale), @Tirupatiuk will be generating GP of £31.2m on revs of £50.4m.
And that's just the Madagascar operations.
#TGR is in the process of acquiring further projects in Mozambique.
6/20
#TGR is acquiring two projects - Montepuez and Balama Central - for a mere £6.6m (£0.8m in cash, £5.6m in TGR shares - issued at a price of 103p, versus the current price of 68p!).
Montepuez is construction ready, and can be built in two modules...
1) Mitigating country risk (no longer relying on just Mad.)
8/20
2) Diversifying resource base. In Madagascar, the concentrate produced is comprised circa 80% large and jumbo flake graphite, 20% small and medium flake.
In Mozambique, it is a 30%/70% split (the other way).
Small/medium flakes are preferred for lithium ion batteries.
9/20
3) Bulking up resource base. The Mozambique acquisition would increase #TGR's in-situ resource tonnage by circa 500%, to 150Mt. Due to the much higher grade deposits than those in Mad., TGR's contained graphite would increase by 12x.
Key for company longevity.
10/20
4) Potential for scaling operations. Bringing the 150kt pa online in Mozambique along with the 84kt pa in Madagascar would put #TGR amongst the top 3-4 graphite producers worldwide, by output.
It would then have not inconsiderable influence in the market and on pricing.
11/20
However, with regards to today's announcement, the key item for me was that TSG had recorded revs of £1.3m in the six months.
In the period, only the 1.2kt pa Patalganga specialty graphite project in India was operating.
This is being expanded by 300%, to 4.8kt pa.
12/20
It is due to come online by start of July next year. Assuming the same run rate as H1 2021, Patalganga will be generating revs of £10.4m pa.
But #TGR is also developing two further speciality graphite modules in India - each with an output of 15kt pa.
The first is due...
13/20
...to come online before the end of next year.
Simply using Patalganga's H1 2021 rev run rate, we could estimate that the first 15kt pa module alone - once at nameplate capacity - will be generating revs of £30m+ pa.
14/20
We don't know what the product mix will be, so that fig can't be taken at face value. But the major upside for @Tirupatiuk evidently lies in the downstream operations.
Can #TGR find the demand for so much speciality graphite?
Given its partnerships with numerous major...
15/20
...players (#TGR has indicated it's been in discussions with multiple players - in multiple regions - in the lithium-ion battery and EV sectors), I'm very confident it can find the demand.
And finally, @Tirupatiuk's third business unit, TGMRC.
This isn't major upside...
16/20
It is genuine, blue sky upside for #TGR. For me, the division is impossible to value at the moment. It can already generate 1kg of graphene per day, which presumably is being shipped off all over the place to various potential customers.
It's been over 6 months since the Al-Gr RNS ⬆️, and I am hoping mgmt breaks its silence on it soon (I have pushed them for an update, and had hoped for one in the interims today).
As I was reminded, if things were NOT going to plan, #TGR would have informed the market.
18/20
When Rolls Royce (a partner currently experimenting with #TGR's Al-Gr comp.) is ready, the market will suddenly wake up.
In the meantime, I'd like to hear how @Tirupatiuk can safeguard this potentially multi-industry-changing material via patents (manufacturing process?).
19/20
To summarise: #TGR is a colossus in the making, in my view. The downstream operations completely set it apart from its peers.
Lack of BFSs (and thus NPVs on the upstream projects) have put some investors off, I feel; as have jurisdictions.
I'm comfortable with the risks.
20/20
• • •
Missing some Tweet in this thread? You can try to
force a refresh
On Monday, #AVCT announced that it had received FDA approval for its Investigational New Drug ('IND') application, to expand its Phase I clinical trial for AVA6000, into trial sites in the US.
The timing of the submission and the length of review are critical.
2/25
The FDA has a 30-day review and turnaround time. Given #AVCT announced the approval this Monday, owing to LSE disclosure laws we must assume it received the approval sometime between Friday and Sunday.
Give a few days for post / admin / comms delays, and we can assume...
...associated with standard doxorubicin, the trial may have been halted already.
On that note, St. James's University Hospital started recruiting, AFTER #AVCT's CEO stated he was "very pleased with the positive progress", re: the first patient at Royal Marsden.
At the current tin price ⬆️, Uis running at nameplate capacity of 1,200 tpa (post ongoing expansion works) would be generating circa £26m EBITDA on circa £36m revs.
The pilot tantalum plant to come online in next few months will provide incremental revs (although at this... 2/6
...stage, unknown), which could grow considerably. Lithium oxide should also come online at Uis Phase 1 - perhaps later next year.
At the current tin price, the expanded Uis Phase 1 (without Ta or Li credits) will have an NPV of $70m to $80m, v. #ATM's current EV of $61m.
3/6
A few more added to the ever-growing @Tirupatiuk holding just now.
The SP is 30% off recent highs, and is still below where it was, pre-acquisition of the Mozambique projects.
Nonsensical. The deal will give #TGR geographical diversification; a broader product range... 1/8
...(the new projects will add small flake graphite to #TGR's offering); a resource base several multiples larger; and, of course, will give @Tirupatiuk much greater production volumes in the medium term.
TGR was already targeting 84 ktpa output in Madagascar; the two new... 2/8
...projects would bring into the fold a potential further 158 ktpa in Mozambique. A 188% increase in total target output for #TGR, over the medium term.
Since the acquisition news, TGR has also brought online its second plant in Madagascar, increasing nameplate capacity... 3/8
@guildesports#GILD is making all the right steps, is expanding incredibly quickly, and winning more trophies than it has had any right to do in its first year of operations.
The Academy could quickly become a key competitive advantage. 1/7
It could create value for #GILD in so many ways. Monthly subscription revs could build quickly - only 17k subscribers would be £1m ARR.
It provides an incredible scouting outlet and feeder system for upcoming talent. Hopefully we’ll see the first academy contracts in the… 2/7
…not too distant. Imagine in a few years’ time #GILD being able to field teams largely or even wholly comprised of Academy-generated talent.
My take on player transfers is that in 2-3 years, Esports transfer values could be 10x the size of what they are today. In 5-7… 3/7
Absolute terror reigns over many #AVCT shareholders this week- simply because @avacta hasn't announced orders for its LFT yet.
Question: would #AVCT be lining up 30m per month capacity overseas, if it thought its existing 5m per month capacity in the UK wouldn't be filled? 1/13
Many seem obsessed with the UK market, thinking that's the be-all and end-all for #AVCT's AffiDX LFT.
My view is that mgmt had turned its back on the UK market several months ago, when it was apparent that there was, at best, complete ineptitude; or, at worst, corruption... 2/13
...at the top of certain UK Gov bodies. I'm referring to both the continued inexplicable support of Innova, and to the stonewalling of @mologic and UK Diagnostics PLC in general.
The FDA's actions against Innova may well have changed #AVCT's stance re: dealing with HMG. 3/13